2024 Press Releases
2023 Press Releases
-
Oct 2023
Benaroya Research Institute’s Dr. Carla Greenbaum Receives Puget Sound Business Journal Lifetime Achievement Award
-
Oct 2023
Benaroya Research Institute Immunologist John Ray Receives 2023 NIH Director’s New Innovator Award
-
Oct 2023
Benaroya Research Institute Receives $9 Million in Funding, With a Focus on Down Syndrome Research
-
Aug 2023
Benaroya Research Institute Awarded $3.1 Million National Institutes of Health Grant to Study the Inflammatory Cycle of Common Skin Diseases
-
Mar 2023
New Study Shows Allergic Asthma Provides Intrinsic Protection Against Severe COVID-19
-
Mar 2023
COVID-19 mRNA Vaccination Does Not Promote Autoantibody Development
-
Jan 2023
New Study Finds That Germinal Centers Are Regulated by Thymic Stromal Lymphopoietin Signaling in B Cells and T Cells
-
Jan 2023
New Study from Benaroya Research Institute and the University of Washington Identify Novel Mechanism of Regulatory T Cells’ Role in Maintaining Immune System Homeostasis
-
Jan 2023
New Study from Benaroya Research Institute Identifies Mechanisms for How Two Air Pollutants Exacerbate Asthma in Urban Children
2022 Press Releases
-
Oct 2022
Benaroya Research Institute Awarded $3.4 Million NIH R01 Grant to Continue Studying Why Immune Responses Are Altered in those with Down Syndrome
-
Oct 2022
New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment
-
Aug 2022
New Asthma Treatment Shows Promise and Future Directions for Disproportionately Affected Kids
-
May 2022
Benaroya Research Institute Team Discovers T cell Based Biomarker and Potential Therapeutic Target for Colon Cancer
-
May 2022
BRI Advances Understanding of the Link Between Genetics and Autoimmune Disease Risk
-
Oct 2023
Benaroya Research Institute’s Dr. Carla Greenbaum Receives Puget Sound Business Journal Lifetime Achievement Award
-
Oct 2023
Benaroya Research Institute Immunologist John Ray Receives 2023 NIH Director’s New Innovator Award
-
Oct 2023
Benaroya Research Institute Receives $9 Million in Funding, With a Focus on Down Syndrome Research
-
Aug 2023
Benaroya Research Institute Awarded $3.1 Million National Institutes of Health Grant to Study the Inflammatory Cycle of Common Skin Diseases
-
Mar 2023
New Study Shows Allergic Asthma Provides Intrinsic Protection Against Severe COVID-19
-
Mar 2023
COVID-19 mRNA Vaccination Does Not Promote Autoantibody Development
-
Jan 2023
New Study Finds That Germinal Centers Are Regulated by Thymic Stromal Lymphopoietin Signaling in B Cells and T Cells
-
Jan 2023
New Study from Benaroya Research Institute and the University of Washington Identify Novel Mechanism of Regulatory T Cells’ Role in Maintaining Immune System Homeostasis
-
Jan 2023
New Study from Benaroya Research Institute Identifies Mechanisms for How Two Air Pollutants Exacerbate Asthma in Urban Children
2022 Press Releases
-
Oct 2022
Benaroya Research Institute Awarded $3.4 Million NIH R01 Grant to Continue Studying Why Immune Responses Are Altered in those with Down Syndrome
-
Oct 2022
New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment
-
Aug 2022
New Asthma Treatment Shows Promise and Future Directions for Disproportionately Affected Kids
-
May 2022
Benaroya Research Institute Team Discovers T cell Based Biomarker and Potential Therapeutic Target for Colon Cancer
-
May 2022
BRI Advances Understanding of the Link Between Genetics and Autoimmune Disease Risk
Oct 2022
Benaroya Research Institute Awarded $3.4 Million NIH R01 Grant to Continue Studying Why Immune Responses Are Altered in those with Down Syndrome
Oct 2022
New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment
Aug 2022
New Asthma Treatment Shows Promise and Future Directions for Disproportionately Affected Kids
May 2022
Benaroya Research Institute Team Discovers T cell Based Biomarker and Potential Therapeutic Target for Colon Cancer
May 2022
